Research teams, sponsors and CROs comparing data collection for clinical trials, from focused participant-centered studies to complex multi-site protocols.
Scope Dedicated EDC systems and participant-centered clinical-trial data collection are compared by their documented capabilities. Whether a participant-centered platform also needs a dedicated EDC depends on in-visit data entry, clinical queries, coding, verification and database-management requirements, rather than study size or trial phase alone.
These notes describe the products in the EDC guide.
Veeva EDC
Best for
Sponsors and CROs already on Veeva's clinical platform who want EDC, RTSM, eCOA and CTMS from the same vendor.
What to consider
Veeva EDC documents mid-study changes and connected clinical applications, and Veeva says eight of the top 20 biopharmas have switched to it. Veeva publishes no study count and no prices.
Clinical trials and research studies that need participant-data collection and ongoing engagement, with consent, forms, ePRO, follow-up and connections to existing systems
What to consider
WeGuide brings participant-data collection and ongoing engagement into one study program for clinical trials and research studies. Teams can run screening, consent, forms, ePRO, reminders and follow-up in a branded participant app. The Integration Engine connects existing research systems when required. If the protocol needs intensive site-entered clinical data, complex queries, medical coding or advanced database management, use an appropriate EDC alongside the participant workflow. Suitability depends on those requirements, rather than study size or phase alone.
Less suitable for
Protocols requiring extensive in-visit eCRFs, complex data queries, medical coding, source-data verification or an enterprise database-lock workflow.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
Veeva EDC vs WeGuide (EDC): category feature evidence and sources. Products are not ranked.
Category feature
Veeva EDC
WeGuide
Track record in regulated multi-site trialsFeature definitions
Supported
Published product or wider-platform adoption, or a named clinical-research deployment.
Extended support
Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
Veeva EDC
Supported
Veeva reports 100+ EDC customers and says eight of the top 20 biopharmas have switched to Veeva EDC, but publishes no study count.
Public research examples include BRACE and INHERIT. These document research use of the participant platform, rather than counts of full enterprise EDC deployments or regulatory submissions.
Named research deployments establish base support; the evidence does not establish full EDC deployment counts.
Study build and mid-study changesFeature definitions
Supported
Study setup or post-go-live study changes are described.
Extended support
Study setup is described, and post-go-live changes explicitly avoid interrupting live study use.
Veeva EDC
Supported
Veeva's white paper states that amendments add new elements without bringing the system down or migrating data, with only a brief casebook lockout while a change deploys.
Amendments avoid system shutdown, but deployment includes a brief casebook lockout.
WeGuide
Supported
Study teams configure forms, question types, conditional logic, input validation and testing. This supports focused trial data collection; uninterrupted enterprise-EDC database amendments are not established by the public material.
Study configuration is documented; a no-interruption EDC amendment workflow is not.
Compliance and securityFeature definitions
Supported
Relevant trial compliance or security controls are stated, with their scope identified.
Extended support
Relevant trial controls and a publicly accessible ISO certificate or SOC audit report covering the product or vendor are documented.
Veeva EDC
Supported
Veeva's trust page lists ISO 27001, ISO 27017, ISO 27018 and a SOC 2 Type II report, and its EDC help docs state that Veeva EDC eSignature meets 21 CFR Part 11.
Part 11 eSignature and ISO/SOC statements are given; public certificate or report access is not established.
WeGuide
Supported
WeGuide states ISO 27001:2022 certification and support for GDPR, HIPAA and 21 CFR Part 11. The public material does not provide the certificate or an audit report.
Connected clinical applications are listed; native medical coding is not established in this note.
WeGuide
Supported
Study programs combine participant forms, ePRO, consent and follow-up. REDCap and other EDC connections can be configured where additional clinical-data workflows require them. A native enterprise EDC, medical-coding and supply-management suite is not claimed.
Connected participant modules and external EDC exchange are documented; the full native-suite definition is not met.
APIs and data standardsFeature definitions
Supported
An API for clinical data exchange is stated.
Extended support
An API plus data exchange in a named CDISC format are documented.
Veeva EDC
Supported
Veeva documents a versioned CDMS API for study data, definitions and coding requests with a data model similar to CDISC ODM, but its ODM casebook export is a legacy feature.